Ondansetron vs Upadacitinib
Ondansetron vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Ondansetron and Upadacitinib.
Mechanism of Action
Ondansetron: Selective 5-HT3 receptor antagonist.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Ondansetron β 3-5 hours; Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Ondansetron β C18H19N3O; Upadacitinib β C17H19F3N6O.
Molecular Weight: Ondansetron β 293.3660 g/mol; Upadacitinib β 380.3700 g/mol.
Type: Ondansetron β Small molecule; Upadacitinib β Small molecule.